adeno-associated virus serotype rh.10 vector expressing bevacizumab (Weill Medical College of Cornell University)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameadeno-associated virus serotype rh.10 vector expressing bevacizumab (Weill Medical College of Cornell University)
Drug Alias NameAAVrh10.BevMab
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionVascular endothelial growth factor receptor antagonists
TargetsVascular endothelial growth factor receptor
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesWeill Medical College of Cornell University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWeill Medical College of Cornell University
Active IndicationsN/A
Inactive IndicationsOvarian Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A